Lv6
2140 积分 2022-09-19 加入
Modular Synthesis of Anti-HER2 Dual-Drug Antibody-Drug Conjugates Demonstrating Improved Toxicity
14天前
已完结
Site-Specific Conjugation to Cys-Engineered THIOMAB™ Antibodies
19天前
已完结
Targeting ADAR1 with a small molecule for the treatment of prostate cancer
22天前
已关闭
Targeting ADAR1 with a Novel Small-Molecule for the Treatment of Prostate Cancer
22天前
已完结
Therapy with oncolytic viruses: progress and challenges
1个月前
已完结
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
2个月前
已完结
PIT565, a First-in-Class Anti-CD19, Anti-CD3, Anti-CD2 Trispecific Antibody for the Treatment of B Cell Malignancies
2个月前
已关闭
PIT565, a First-in-Class Anti-CD19, Anti-CD3, Anti-CD2 Trispecific Antibody for the Treatment of B Cell Malignancies
2个月前
已关闭
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
2个月前
已完结
The hallmarks of cancer immune evasion
2个月前
已完结
皖公网安备34019202002308
